The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold
Isomorphic Labs has unveiled its new Drug Design Engine, which significantly outperforms AlphaFold 3 in predicting protein-ligand structures and binding affinities. This computational tool aims to accelerate drug discovery by enabling the rational design of medicines with higher precision and lower costs.
Why it matters
Advancements in AI-driven drug discovery could drastically reduce the time and cost required to bring life-saving medications to market.
Our Tech Partnerships Careers Life At Iso Work With Us Job Openings News Our Team Our Tech Partnerships Careers Life at Iso Work with Us Job Openings News Vision The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold February 10, 2026 min Read min Read min Read min Read min listen min watch Copy url Table of Contents Listen: Spotify Apple Podcasts Today, we are excited to share an update on our progress towards a new frontier of drug design. We have unlocked a new paradigm of predictive accuracy in understanding our biomolecular world, allowing us to rationally design new medicines on a computer with unprecedented understanding and precision. We are giving a glimpse at a subset of the powerful and expansive capabilities of the Isomorphic Labs Drug Design Engine (IsoDDE), a unified computational drug-design system, progressing beyond AlphaFold 3 (AF3) in its predictive accuracy and introducing new capabilities which bridge the gap between structure prediction and real-world drug discovery.
The content is a technical announcement regarding scientific progress without political or social commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in